James R. Dilks
- Molecular Biology
- Hematology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 10%
- Cell Biology top 5%
- Co-authors
- Robert FlaumenhaftDouglas I. LinSabina SignorettiMassimo LodaLevi A. GarrawayDavid WaltregnyRodolfo MontironiAnnie Yang
- Topics
- Platelet Disorders and Treatments (13 papers)Blood Coagulation and Thrombosis Mechanisms (5 papers)Endoplasmic Reticulum Stress and Disease (4 papers)
- Partner nations
- United StatesBelgiumItaly
In The Last Decade
James R. Dilks
23 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 642
- Hematology 434
- Pulmonary and Respiratory Medicine 426
- Oncology 292
- Cell Biology 219
Countries citing papers authored by James R. Dilks
This map shows the geographic impact of James R. Dilks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Dilks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Dilks more than expected).
Fields of papers citing papers by James R. Dilks
This network shows the impact of papers produced by James R. Dilks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Dilks. The network helps show where James R. Dilks may publish in the future.
Co-authorship network of co-authors of James R. Dilks
This figure shows the co-authorship network connecting the top 25 collaborators of James R. Dilks. A scholar is included among the top collaborators of James R. Dilks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. Dilks. James R. Dilks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 68 | |
| 3 | Identification of ML359 as a Small Molecule Inhibitor of Protein Disulfide Isomerase | 16 |
| 4 | 33 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | 236 | |
| 8 | 3 | |
| 9 | Chemical Genetic Analysis of Platelet Granule Secretion-Probe 1 | 3 |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 66 | |
| 13 | 3 | |
| 14 | 236 | |
| 15 | 32 | |
| 16 | 1 | |
| 17 | 108 | |
| 18 | 77 | |
| 19 | The p27 ubiquitin ligase skp2 is overexpressed in breast cancer | 1 |
| 20 | 465 |
About James R. Dilks
James R. Dilks is a scholar working on Hematology, Immunology and Allergy and Urology, having authored 23 papers that have together received 1.5k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (13 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). The work is most often cited by research in Hematology (434 citations), Internal Medicine (64 citations) and Cell Biology (219 citations). James R. Dilks has collaborated with scholars based in United States, Belgium and Italy. Frequent co-authors include Robert Flaumenhaft, Douglas I. Lin, Sabina Signoretti, Massimo Loda, Levi A. Garraway, David Waltregny, Rodolfo Montironi, Annie Yang, Frank McKeon and Beth Isaac. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.